Knee News

DALLAS — In this video from the American Association of Hip and Knee Surgeons Annual Meeting, Robert A. Burnett, MD, discussed results that showed repeat mesh glue dressing exposure yielded a fivefold increased risk of allergic dermatitis.

DALLAS — Results presented here showed the perception of work-life balance approached significant difference among male and female orthopedic surgeons, as well as among physicians initially interested in arthroplasty.

WASHINGTON — Patients treated with a novel neurotrophin-3 inhibitor demonstrated significant reductions in osteoarthritis knee pain across all dosing levels, according to data presented at ACR Convergence 2024.

WASHINGTON — Lorecivivint is superior to placebo for improving pain, function and structure at 12 months and beyond in patients with knee osteoarthritis, according to data presented at ACR Convergence 2024.

DALLAS — Data presented at the American Association of Hip and Knee Surgeons Annual Meeting showed use of intraosseous vancomycin infusion may reduce periprosthetic joint infection vs. IV vancomycin in revision total knee arthroplasty.

Most of the surgeons in our group have a strong preference for using intramedullary fixation for distal femoral periprosthetic fractures.

Reported as the most frequently performed orthopedic procedures in the United States, research has projected an estimated increase in total hip and knee procedures of 176% and 139%, respectively, by 2040.

DALLAS — In this video, Christopher N. Carender, MD, discussed results that showed surgeon volume may not be a modifiable risk factor for revision and periprosthetic joint infection after total knee arthroplasty in patients with obesity.

DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results.